The Valley Desk

ArticleRegulatory toxicology and pharmacology : RTPPublished

Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Merck & Co. Affiliation source

Publication record

Type
Article
Venue
Regulatory toxicology and pharmacology : RTP
Published
Subject terms
Animals; Primates; Humans; Neoplasms; Antineoplastic Agents; Antibodies, Bispecific; Drug Evaluation, Preclinical; CD3 Complex; Drug Development; Survey; Case Studies; Non-human Primate
PubMed ID
40685066
Added to directory
Source checked

Report a correction or request removal